Eli
Montréal
About Eli
Eli Health is building the real-time interface to the human body, making it possible to improve daily and lifelong health through instant access to essential biological signals. Its flagship product, the Hormometer™, is the world’s first instant hormone monitoring system’delivering results from a saliva sample to your phone in minutes. No more snapshots, just a live feed. Hormones govern how we feel, function, perform, and age. Yet 60% of adults will experience hormone-related symptoms, and 1 in 3 are affected by cortisol dysregulation. Until now, real-time hormone tracking hasn’t existed. That changes with Eli. Our goal was simple: make hormone monitoring as easy as brushing your teeth and as affordable as a daily coffee’something anyone could do, every day. The path, however, was anything but. After over five years of R&D and 12+ patent-pending innovations, our multidisciplinary team made that vision a reality. In 2025, the Hormometer™ was awarded CES Best of Innovation in Digital Health, recognized as a category-defining breakthrough. Just as the thermometer and glucometer transformed everyday care, Eli marks the next evolution in data-driven health. Apply for early access or to join our team: www.eli.health
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $18.7M
- Funding stage: Early Stage Venture
- Last round: Series A (Jun 2025)
- Website: eli.health
- Phone: [email protected]
Industries & Categories
Health Care, Personal Health, Women's
Social Profiles
Canonical: https://fsome.com/organization/eli-56019 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.